ZA200802246B - Engineered antibodies with new world primate framework regions - Google Patents

Engineered antibodies with new world primate framework regions

Info

Publication number
ZA200802246B
ZA200802246B ZA200802246A ZA200802246A ZA200802246B ZA 200802246 B ZA200802246 B ZA 200802246B ZA 200802246 A ZA200802246 A ZA 200802246A ZA 200802246 A ZA200802246 A ZA 200802246A ZA 200802246 B ZA200802246 B ZA 200802246B
Authority
ZA
South Africa
Prior art keywords
framework regions
engineered antibodies
new world
world primate
primate framework
Prior art date
Application number
ZA200802246A
Other languages
English (en)
Inventor
Jennings Anthony Philip
Doyle Gerard Anthony
Clarke Adam William
Gay Robert Daniel
Original Assignee
Arana Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005904406A external-priority patent/AU2005904406A0/en
Application filed by Arana Therapeutics Ltd filed Critical Arana Therapeutics Ltd
Publication of ZA200802246B publication Critical patent/ZA200802246B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
ZA200802246A 2005-08-15 2006-08-15 Engineered antibodies with new world primate framework regions ZA200802246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2005904406A AU2005904406A0 (en) 2005-08-15 New World Antibodies

Publications (1)

Publication Number Publication Date
ZA200802246B true ZA200802246B (en) 2009-09-30

Family

ID=37757238

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200802247A ZA200802247B (en) 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions
ZA200802246A ZA200802246B (en) 2005-08-15 2006-08-15 Engineered antibodies with new world primate framework regions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200802247A ZA200802247B (en) 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions

Country Status (13)

Country Link
EP (1) EP1945669A4 (xx)
JP (1) JP2009504686A (xx)
KR (1) KR20080068005A (xx)
CN (2) CN101287763A (xx)
AU (1) AU2006281981A1 (xx)
BR (2) BRPI0614867A2 (xx)
CA (1) CA2619245A1 (xx)
MX (1) MX2008002161A (xx)
NO (1) NO20080800L (xx)
NZ (1) NZ565904A (xx)
RU (1) RU2008110058A (xx)
WO (1) WO2007019621A1 (xx)
ZA (2) ZA200802247B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20070027A (xx) 2004-07-26 2008-11-28 Biogen Idec Ma Inc., Antitela anti-cd154
NZ569988A (en) 2006-02-01 2011-09-30 Cephalon Australia Pty Ltd Domain antibody construct which binds to human TNF-alpha and contains a modified hinge region sequence and a truncated CH1 domain
HUE041818T2 (hu) * 2007-03-22 2019-05-28 Biogen Ma Inc Kötõ proteinek, beleértve az antitesteket, CD154-et specifikusan kötõ antitest származékokat és antitest fragmenseket is, és alkalmazásaik
US20110319597A1 (en) * 2008-08-14 2011-12-29 Caphalon Australia Pty. Ltd. Variant domain antibodies
RU2516931C2 (ru) * 2010-08-06 2014-05-20 Олег Ильич Эпштейн Способ и композиция для профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2577299C2 (ru) * 2011-07-04 2016-03-10 Олег Ильич Эпштейн Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2521392C2 (ru) * 2010-08-06 2014-06-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения вирусных заболеваний и способ лечения вирусных заболеваний
RU2505312C2 (ru) * 2010-08-06 2014-01-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения гриппа различных типов
RU2519862C2 (ru) * 2010-08-06 2014-06-20 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики и лечения инфекционных вирусных заболеваний
RU2535034C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2502521C2 (ru) * 2010-08-06 2013-12-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций
RU2517085C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2579262C1 (ru) * 2014-10-02 2016-04-10 Мапикс Эс.Эй.Ар.Эл. Лекарственное средство для лечения инфекционных заболеваний
CL2015002152A1 (es) * 2015-07-31 2016-06-03 Pontificia Universidad Católica De Chile Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285046B6 (sk) * 1991-07-25 2006-05-04 Idec Pharmaceuticals Corporation Chimérna protilátka, ktorá sa špecificky viaže na ľudský antigén, farmaceutický prostriedok s jej obsahom, spôsob jej výroby a použitie
US6569431B2 (en) * 2000-10-17 2003-05-27 The Regents Of The University Of California Recombinant antibody fragments as autoantibody antagonists
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
DK1517921T3 (da) * 2002-06-28 2006-10-09 Domantis Ltd Immunglobulin-enkeltvariable antigen-bindende domæner og dobbeltspecifikke konstruktioner deraf
WO2005047325A2 (en) * 2003-11-07 2005-05-26 Amgen Inc. Monkey immunoglobulin sequences

Also Published As

Publication number Publication date
MX2008002161A (es) 2008-04-22
BRPI0614430A2 (pt) 2011-03-29
EP1945669A1 (en) 2008-07-23
NO20080800L (no) 2008-05-09
BRPI0614867A2 (pt) 2012-01-31
ZA200802247B (en) 2009-08-26
WO2007019621A1 (en) 2007-02-22
KR20080068005A (ko) 2008-07-22
EP1945669A4 (en) 2009-07-22
RU2008110058A (ru) 2009-09-27
CN101287763A (zh) 2008-10-15
AU2006281981A1 (en) 2007-02-22
CA2619245A1 (en) 2007-02-22
CN101287762A (zh) 2008-10-15
JP2009504686A (ja) 2009-02-05
NZ565904A (en) 2012-02-24

Similar Documents

Publication Publication Date Title
EP1945668A4 (en) SYNTHETIC ANTIBODIES WITH FRAMEWORK REGIONS OF NEUWELTPRIMATEN
ZA200802246B (en) Engineered antibodies with new world primate framework regions
HUS1900050I1 (hu) Konstruált anti-IL-23 antitestek
HRP20182174T1 (hr) Anti-il-23p19 antitijela proizvedena genetičkim inženjeringom
ZA200904078B (en) Engineered anti-tslp antibody
PT1874927E (pt) Celulases melhoradas
EP2078249A4 (en) MIDDLEWARE-FRAMEWORK
IL200581A0 (en) Engineered anti-il-23r antibodies
EP1969009A4 (en) CHIMERIC ANTIBODIES AT PRIMATE PARTIAL BINDING REGIONS OF THE NEW WORLD
GB0517487D0 (en) Antibodies
GB0500604D0 (en) Novel process
EP1896047A4 (en) ANTI-GFRALPHA3 ANTIBODIES
GB0505489D0 (en) Antibodies
GB0503189D0 (en) Spinning top
GB0512278D0 (en) Antibodies
GB0505054D0 (en) Antibodies
GB0508586D0 (en) Engineered enzymes
GB0508425D0 (en) Engineered enzymes
EG23987A (en) Development of simple, economic inverted microscope
GB0502767D0 (en) Software application framework
AU309830S (en) Lattice border assembly
GB0519883D0 (en) Antibodies
AU316717S (en) Swimwear top
AU303428S (en) Jar
GB0504504D0 (en) Cyanation process